BioSyent Inc.
RX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.64% | 33.51% | -9.76% | 40.27% | -31.90% |
| Total Depreciation and Amortization | -13.77% | 68.86% | -24.11% | 2.20% | 64.29% |
| Total Amortization of Deferred Charges | 109.04% | -184.49% | 1,290.63% | -88.57% | -- |
| Total Other Non-Cash Items | 303.41% | -95.38% | -224.20% | -92.62% | 461.90% |
| Change in Net Operating Assets | 1,918.56% | -105.00% | 140.17% | -778.74% | -89.24% |
| Cash from Operations | 24.43% | -19.87% | 601.16% | -126.77% | -61.36% |
| Capital Expenditure | -206.52% | 168.15% | 2.88% | -120.63% | 31.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 442.00% | 131.18% | -82.05% | 20.36% | 117.29% |
| Cash from Investing | 423.58% | 163.82% | -83.51% | 19.34% | 117.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.86% | -2.92% | -1.05% | -1.93% | -1.30% |
| Issuance of Common Stock | -100.00% | 446.03% | -89.23% | -63.93% | 223.11% |
| Repurchase of Common Stock | 26.19% | 28.51% | 97.54% | 74.78% | -16,515.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.20% | -0.52% | -3.62% | -7.12% | 4.16% |
| Other Financing Activities | 4.96% | 3.97% | 3.82% | 6.43% | 4.11% |
| Cash from Financing | -3.97% | 4.82% | 56.31% | 64.68% | -637.69% |
| Foreign Exchange rate Adjustments | -274.51% | 202.00% | -900.00% | -102.24% | 217.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.08% | -12.14% | 367.90% | -69.34% | -166.27% |